Trident Bioscience Analysis: $150K Raised
What is Trident Bioscience?
GoDaddy is a leading provider of domain registration and web hosting services. Their unique approach combines user-friendly tools with 24/7 expert support, making it easy for individuals and businesses to establish an online presence. This enables users to create websites, manage domains, and implement marketing strategies effectively.
Location
100 S Mill Ave, Tempe, Arizona 85281, United States
Employees
5001-10000
Founded
1997
Revenue
$947K
Investors
- Y Combinator
Product Features & Capabilities
- Trident Chemwidgets, machine learning operations (MLOps) platform, predictive models for protein discovery, tools for biochemical data input and analysis, optimization of useful proteins.
How much Trident Bioscience raised
Seed - $150,000
August 25, 2020Lead Investor: Y Combinator
Who are the founders of Trident Bioscience
TS
Tyler Shimko
Founder
Market Focus
Trident Bioscience primarily focuses on the biotechnology industry, specifically developing a machine learning operations (MLOps) platform that integrates biochemical data with machine learning processes.
Competitors Overview
Trident Bioscience operates in the biotechnology sector, focusing on machine learning operations (MLOps) for integrating biochemical data. Its main competitors include:
-
Insilico Medicine: This company develops technologies to accelerate drug discovery and development, aiming to extend healthy longevity. Insilico's advantage lies in its comprehensive approach to drug discovery, utilizing AI to streamline the process significantly.
-
Exscientia: Exscientia combines advanced AI technology with drug discovery, focusing on precision-engineered medicines. Its notable advantage is the integration of AI throughout the drug design process, which enhances the likelihood of success in developing new compounds.
-
BenevolentAI: A leader in applying AI to drug discovery, BenevolentAI aims to increase the probability of success in drug development, which traditionally has a high failure rate. Its technology is designed to reduce timelines and improve outcomes in complex disease treatment.
-
Owkin: This company specializes in using AI to understand complex biology, optimizing clinical trials and developing AI diagnostics. Owkin's unique approach includes federated learning, which allows for decentralized data analysis, enhancing patient privacy and data security.
-
Nference: Nference provides an AI-based platform that synthesizes biomedical knowledge to advance diagnostics and therapeutics. Its strength lies in leveraging electronic medical records (EMRs) to extract valuable insights, which can significantly enhance drug development processes.
These competitors differ from Trident Bioscience in their specific applications of AI and machine learning, as well as their approaches to drug discovery and development, which may offer distinct advantages in terms of speed, efficiency, and success rates in bringing new therapies to market.
See something that needs updating? Suggest edits to this profile.